started · updated
Italy faces diabetes challenges amid potential new weekly treatments
Approximately 3.8 million people in Italy are living with a diabetes diagnosis, representing 6.4% of the population. An additional 1 million people may be living with the condition undiagnosed. Over 90% of these cases involve type 2 diabetes.
In therapeutic developments, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a favorable opinion on a new combination of weekly basal insulin icodec and weekly semaglutide. This formulation aims to improve glycemic control and reduce treatment complexity by combining two complementary mechanisms of action. Experts suggest Italy could be among the first European nations to make this weekly administration available.
Recent research by AstraRicerche for the Unione Italiana Food highlights the impact of daily habits on metabolic health. The study found that 91.5% of Italians engage in micro-habits that negatively affect glycemic peaks, such as eating while watching screens. Health professionals recommend post-meal walks, consistent meal timing, and pairing carbohydrates with fiber to manage blood sugar levels.
Entities
AstraRicerche · European Medicines Agency · Francesco Giorgino · Italy · Unione Italiana Food
Claims
What the coverage asserts, and how many sources carry each claim.
- [○ 1 SOURCE] 91.5% of Italians engage in micro-habits that impact glycemic peaks. www.quotidianodelsud.it
- [● 2 SOURCES] Approximately 3.8 million people in Italy have been diagnosed with diabetes. canaledieci.it · www.redazionenews.it
- [● 2 SOURCES] The CHMP of the EMA expressed a favorable opinion on a combination of weekly basal insulin icodec and weekly semaglutide. canaledieci.it · www.redazionenews.it
- [● 2 SOURCES] Over 1 million people in Italy may have diabetes without a diagnosis. canaledieci.it · www.redazionenews.it
- [● 2 SOURCES] More than 90% of diabetes cases are type 2 diabetes. canaledieci.it · www.redazionenews.it